We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Mr Marc Laniado at Spire include:
Mr Marc Laniado is dedicated to returning men to as normal a life as possible when suffering from prostate enlargement or with prostate cancer. He is highly experienced and works full time in the direct clinical care of men with prostate problems. As the prostate cancer and multidisciplinary urological cancer lead, he has developed and delivers minimally invasive techniques daily that have significantly helped his patients. He provides individually-tailored therapies alleviating urinary symptoms or reducing the chance of dying from prostate cancer, with the greatest chance of preserving erections, ejaculation and bladder control.
Mr Marc Laniado graduated from Guy's Hospital Medical School in 1989, having previously gained a BSc in physiology. Following specialist urology training in London, he became a Fellow of the Royal College of Surgeons (Urology) in 2000, going on to complete his MD in prostate cancer research, Fellow of the European Board of Urology in 2002 and international member of the American Urological Association. Prior to taking up his career as a consultant, Mr Laniado extended his knowledge and skills on a Visiting Fellowship at the Cleveland Clinic Foundation in the USA, where he trained in minimally invasive surgical techniques. Mr Laniado was appointed as a consultant to Wexham Park Hospital (Frimley Health) in 2002, where he is the lead for prostate cancer. specialising in rapid diagnostic techniques and minimally invasive treatments for prostatic enlargement and prostate cancer. He is the prostate cancer lead clinician and urological cancer multidisciplinary lead. His private practice is based in Harley Street, London, and Berkshire.
Mr Laniado is a highly-respected specialist, with over 15 years experience in full-time, direct care of men without distraction from other non-clinical activities. Using a unique range of skills, which are audited, he offers a personalised approach to prostate enlargement or prostate cancer, tailoring tests and treatment to the individual with the specific aim of preserving continence, erections and ejaculation in selected men.
Prostate enlargement (BPH): Mr Laniado offers expert assessment and treatment of urinary symptoms caused by prostate enlargement (benign prostatic hyperplasia, BPH), such as increased frequency, slow flow and getting up in the night. When lifestyle changes and medications fail to improve symptoms, Mr Laniado offers the UroLift procedure, which alleviates urinary symptoms without affecting erections or ejaculation. It is a minimally-invasive, day-case procedure performed without a catheter. In a man with a prostate that is unsuitable for UroLift, Mr Laniado performs a laser prostatectomy (HoLEP) as a day-case or overnight stay, which has the advantage of minimal bleeding and fewer side-effects compared to the more common procedure know as TURP. His has also developed a modified method of HoLEP (epHoLEP) that is designed to preserve normal ejaculation in selected men.
Prostate cancer: Mr Laniado has been responsible for the development of innovative pathways and treatments that benefit all men at risk of prostate cancer. He uses multiparametric MRI to determine the risk and to decide whether further investigations, such as MRI-targeted transperineal prostate biopsies are needed. These biopsies are much more accurate and safer than the more frequently used unguided transrectal prostate biopsies. He also uses the new urine test SelectMDx to avoid biopsies in some situations. When prostate cancer is detected, in suitable cases Mr Laniado considers active surveillance (AS) or focal therapy with HIFU, which is a technique that preserves bladder control and erections. To help decide on the need for treatment, the Prolaris biomarker, is sometimes used to identify cancers that are not life-threatening. Where the cancer is not suitable for either AS or focal therapy, he offers either brachytherapy or a Retzius-sparing prostatectomy, which is a new technique that preserves bladder control almost completely, and better than any other surgical method for removing the prostate. As a full-time clinician in the daily management of men with prostate disease, he regularly performs these procedures regularly.
Special Clinical Interests: Men at risk or with prostate cancer, urinary symptoms due to the prostate and techniques to improve symptoms with few side-effects.
MB BS BSc (Hons) MD / London / 1989
Bachelor of Medicine, Bachelor of Surgery, Bachelor of Science, Doctor of Medicine
British Association of Urological Surgeons
American Urological Association
European Association of Urology
Royal College of Surgeons of England
British Medical Association
Heatherwood and Wexham Park Hopsital NHS TrustBack to top
I was born in Hampstead and lived in north and west London most of my life until moving to Windsor. I met my wife whilst presenting research at the American Urological Association in 1996 and we have twin boys. Outside urology, my life revolves around my family, I enjoy tennis, wind surfing, running and, when possible, skiing.Back to top
|Private secretary||Zoe Cowie|
|Private secretary telephone||01753 860071|
|Private secretary firstname.lastname@example.org|
19 July 2019
Spire’s CEO, Justin Ash, talks about his mammoth 326km team cycle challenge from London to Bristol, the pinnacle of a bu…
24 June 2019
Spire Manchester Hospital has been rated CQC ‘Outstanding’ overall following inspection in February 2019